Health Trials

Cytokine Storm

3

Review clinical trials related to Cytokine Storm. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Jafron Cytokine Adsorber During Pediatric Open-Heart Surgeries

This prospective single-center randomized controlled trial aims at evaluating the safety and feasibility of an hemoadsorption protocol using Jafron HA-60 during cardio-pulmonary bypass in 20 pediatric patients undergoing open-heart surgery.

Participants needed: 20
Trial details
Age: Up to 10Biological sex: AllType: InterventionalSponsor: Centre Hospitalier Universitaire VaudoisUpdated: Feb 10, 2026Locations: 1
Eligibility criteria

Children ≤ 10 years old at study inclusion [+3]

Children having an indication to receive hemoadsorption during CPB for drugs rem... [+7]

Read more
Status: Not yet recruiting

MRG-001 as an Immunoregulatory and Regenerative Therapy for ARDS Patients

This is a phase IIa, dose-ranging, proof-of-concept study of MRG-001 in patients with ARDS. The aim is to determine the safety and preliminary efficacy of MRG-001 across two dose ranges.

Participants needed: 60
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: MedRegen LLCUpdated: Aug 23, 2024
Eligibility criteria

Chest x-ray (CXR)* revealing bilateral infiltrates involving a minimum of three... [+2]

Age less than 18 years. [+9]

Read more
Status: Recruiting

Clinical Outcomes and Inflammatory Responses in Viral vs. Bacterial Sepsis

This observational cohort study aims to compare clinical outcomes and inflammatory responses between patients with viral sepsis, specifically COVID-19-associated sepsis, and those with bacterial sepsis. Conducted at Sichuan Provincial People's Hospital, the study will retrospectively analyze data from ICU patients admitted between July 2021 and December 2023. The primary objective is to identify reliable biomarkers and diagnostic methods to improve patient outcomes through personalized diagnostic and therapeutic strategies.

Participants needed: 300
Trial details
Age: 18-90Biological sex: AllType: ObservationalSponsor: Sichuan Provincial People's HospitalUpdated: Jul 9, 2024Locations: 1
Eligibility criteria

Patients diagnosed with sepsis according to Sepsis 3.0 criteria. [+4]

Patients with mixed bacterial and viral infections. [+3]

Read more